Cholesterol in younger men

NEW YORK, July 19 (Praxis Press) Using serum cholesterol levels to predict coronary heart disease (CHD) and whether to treat hypercholesterolemia in people under the age of 40 is controversial. To evaluate the long-term impact of unfavorable serum cholesterol levels on risk of death from CHD, cardiovascular disease (CVD), and all causes, Stamler and colleagues evaluated a total of 11,017 men aged 18 through 39 years from three large prospective studies (see paper). The researchers measured cause

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 19 (Praxis Press) Using serum cholesterol levels to predict coronary heart disease (CHD) and whether to treat hypercholesterolemia in people under the age of 40 is controversial. To evaluate the long-term impact of unfavorable serum cholesterol levels on risk of death from CHD, cardiovascular disease (CVD), and all causes, Stamler and colleagues evaluated a total of 11,017 men aged 18 through 39 years from three large prospective studies (see paper). The researchers measured cause-specific mortality during several years of follow-up, mortality risks, and estimated life expectancy in relation to baseline serum cholesterol levels. They found that men with serum cholesterol levels of 240 mg/dL or greater, versus favorable levels (<200 mg/dL), had a 2.15 to 3.63 times greater CHD mortality risk; a 2.10 to 2.87 times greater CVD disease mortality risk; and a 1.31 to 1.49 times greater all-cause mortality risk. In younger men, elevated serum cholesterol ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform